The Extension study : Using TOfogliflozin for Possible better Intervention against Atherosclerosis for Type 2 Diabetes Patients
Not Applicable
- Conditions
- type 2 diabetes mellitus
- Registration Number
- JPRN-UMIN000032601
- Lead Sponsor
- Osaka University Graduate School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 340
Inclusion Criteria
Not provided
Exclusion Criteria
Those subjects who meet one of the following criteria are excluded: 1. subjects who disagree to participate in this Extension study 2. subjects determined ineligible by an investigator
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method